BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 27908728)

  • 21. Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis.
    Russell M; Thompson F; Spier C; Taetle R
    Leukemia; 1993 Oct; 7(10):1654-7. PubMed ID: 8412328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
    Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.
    Abrahamsson AE; Geron I; Gotlib J; Dao KH; Barroga CF; Newton IG; Giles FJ; Durocher J; Creusot RS; Karimi M; Jones C; Zehnder JL; Keating A; Negrin RS; Weissman IL; Jamieson CH
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3925-9. PubMed ID: 19237556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.
    Xu L; Lu Y; Lai J; Yu W; Zhang Y; Jin Z; Xu Y; Chen J; Zha X; Chen S; Yang L; Li Y
    Sci China Life Sci; 2015 Dec; 58(12):1276-81. PubMed ID: 26423566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.
    Coluccia AM; Vacca A; Duñach M; Mologni L; Redaelli S; Bustos VH; Benati D; Pinna LA; Gambacorti-Passerini C
    EMBO J; 2007 Mar; 26(5):1456-66. PubMed ID: 17318191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of beta-Catenin Gene in CML and its relationship with bcr/abl].
    Li ZJ; Qiu LG; Li X; Mai YJ; Wang GR; Yu Z; Wang YF; Li CH; Li Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):931-5. PubMed ID: 17956664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibition.
    Niu CC; Zhao C; Yang ZD; Zhang XL; Wu WR; Pan J; Zhao C; Li ZQ; Ding W; Yang Z; Si WK
    Int J Mol Med; 2013 Feb; 31(2):453-8. PubMed ID: 23233089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.
    Nakahara F; Kitaura J; Uchida T; Nishida C; Togami K; Inoue D; Matsukawa T; Kagiyama Y; Enomoto Y; Kawabata KC; Chen-Yi L; Komeno Y; Izawa K; Oki T; Nagae G; Harada Y; Harada H; Otsu M; Aburatani H; Heissig B; Hattori K; Kitamura T
    Blood; 2014 Jun; 123(25):3932-42. PubMed ID: 24825862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.
    Miyazaki K; Yamasaki N; Oda H; Kuwata T; Kanno Y; Miyazaki M; Komeno Y; Kitaura J; Honda Z; Warming S; Jenkins NA; Copeland NG; Kitamura T; Nakamura T; Honda H
    Blood; 2009 May; 113(19):4702-10. PubMed ID: 19234145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine activates blast-phase chronic myeloid leukemia cells and alleviates the effects of tyrosine kinase inhibitors.
    Zhou Z; Liu T; Zhang J
    Biochem Biophys Res Commun; 2019 Dec; 520(3):560-565. PubMed ID: 31615652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis.
    Ashur-Fabian O; Adamsky K; Trakhtenbrot L; Cohen Y; Raanani P; Hardan I; Nagler A; Rechavi G; Amariglio N
    Cell Cycle; 2007 Mar; 6(5):589-94. PubMed ID: 17361096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia.
    Karabay AZ; Koc A; Ozkan T; Hekmatshoar Y; Altinok Gunes B; Sunguroglu A; Buyukbingol Z; Atalay A; Aktan F
    Hematology; 2018 Dec; 23(10):765-770. PubMed ID: 29945498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biphenotypic blast crisis of chronic myelogenous leukemia: abnormalities of p53 and retinoblastoma genes.
    Ishikura H; Yufu Y; Yamashita S; Abe Y; Okamura T; Motomura S; Nishimura J; Nawata H
    Leuk Lymphoma; 1997 May; 25(5-6):573-8. PubMed ID: 9250829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26).
    Suzukawa K; Taki T; Abe T; Asoh H; Kamada N; Yokota J; Morishita K
    Genomics; 1997 Jun; 42(2):356-60. PubMed ID: 9192861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
    Storlazzi CT; Anelli L; Albano F; Zagaria A; Ventura M; Rocchi M; Panagopoulos I; Pannunzio A; Ottaviani E; Liso V; Specchia G
    Ann Hematol; 2004 Feb; 83(2):78-83. PubMed ID: 14551738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia.
    Roy S; Jørgensen HG; Roy P; Abed El Baky M; Melo JV; Strathdee G; Holyoake TL; Bartholomew C
    Br J Haematol; 2012 May; 157(4):446-56. PubMed ID: 22372463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EVI1 targets platelet endothelial cell adhesion molecule and up-regulates its expression in chronic myeloid leukemia.
    Pradhan AK; Chakraborty S
    Leuk Lymphoma; 2014 Apr; 55(4):954-6. PubMed ID: 23772643
    [No Abstract]   [Full Text] [Related]  

  • 39. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
    Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C
    Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.
    Mukherjee K; Sha X; Magimaidas A; Maifrede S; Skorski T; Bhatia R; Hoffman B; Liebermann DA
    Oncotarget; 2017 Feb; 8(7):10809-10821. PubMed ID: 28086219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.